EPIGRAL LIMITED Intrinsic Value
EPIGRAL · Chemicals · Current price ₹1,051.9
Is EPIGRAL LIMITED undervalued?
DocStoX estimates the fair value of EPIGRAL LIMITED at ₹1,479 per share, versus the current market price of ₹1,052. That puts the stock about +40.6% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹572), Relative P/E (₹3,739), Graham floor (₹979). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹572 (bear) to ₹1,479 (base) to ₹3,739 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,052 versus an intrinsic value of ₹1,479, EPIGRAL LIMITED currently offers +40.6% of margin.
More on EPIGRAL LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.